260 related articles for article (PubMed ID: 31364741)
1. Transcriptional regulation of FoxM1 by HIF‑1α mediates hypoxia‑induced EMT in prostate cancer.
Tang C; Liu T; Wang K; Wang X; Xu S; He D; Zeng J
Oncol Rep; 2019 Oct; 42(4):1307-1318. PubMed ID: 31364741
[TBL] [Abstract][Full Text] [Related]
2. FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.
Liu Y; Liu Y; Yuan B; Yin L; Peng Y; Yu X; Zhou W; Gong Z; Liu J; He L; Li X
Oncotarget; 2017 Mar; 8(10):17027-17037. PubMed ID: 28199985
[TBL] [Abstract][Full Text] [Related]
3. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.
Xia L; Mo P; Huang W; Zhang L; Wang Y; Zhu H; Tian D; Liu J; Chen Z; Zhang Y; Chen Z; Hu H; Fan D; Nie Y; Wu K
Carcinogenesis; 2012 Nov; 33(11):2250-9. PubMed ID: 22831955
[TBL] [Abstract][Full Text] [Related]
4. Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer.
Wang Y; Yao B; Wang Y; Zhang M; Fu S; Gao H; Peng R; Zhang L; Tang J
Int J Mol Med; 2014 Jun; 33(6):1514-22. PubMed ID: 24676803
[TBL] [Abstract][Full Text] [Related]
5. DAB2IP regulates EMT and metastasis of prostate cancer through targeting PROX1 transcription and destabilizing HIF1α protein.
Wang B; Huang J; Zhou J; Hui K; Xu S; Fan J; Li L; Wang X; Hsieh JT; He D; Wu K
Cell Signal; 2016 Nov; 28(11):1623-30. PubMed ID: 27476001
[TBL] [Abstract][Full Text] [Related]
6. [Role of beta-catenin signaling pathway in EMT of human prostate cancer induced by HIF-1alpha].
Luo Y; He DL; Jiang YG; Ning L; Shen SL; Zhao JH; Cui XH
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(16):1131-6. PubMed ID: 20646434
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional up-regulation of FoxM1 in response to hypoxia is mediated by HIF-1.
Xia LM; Huang WJ; Wang B; Liu M; Zhang Q; Yan W; Zhu Q; Luo M; Zhou ZZ; Tian DA
J Cell Biochem; 2009 Feb; 106(2):247-56. PubMed ID: 19097132
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.
Wu JB; Shao C; Li X; Li Q; Hu P; Shi C; Li Y; Chen YT; Yin F; Liao CP; Stiles BL; Zhau HE; Shih JC; Chung LW
J Clin Invest; 2014 Jul; 124(7):2891-908. PubMed ID: 24865426
[TBL] [Abstract][Full Text] [Related]
9. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells.
Zuo J; Guo Y; Peng X; Tang Y; Zhang X; He P; Li S; Wa Q; Li J; Huang S; Xu D
Oncol Rep; 2015 Mar; 33(3):1388-94. PubMed ID: 25571882
[TBL] [Abstract][Full Text] [Related]
11. Foxm1 expression in prostate epithelial cells is essential for prostate carcinogenesis.
Cai Y; Balli D; Ustiyan V; Fulford L; Hiller A; Misetic V; Zhang Y; Paluch AM; Waltz SE; Kasper S; Kalin TV
J Biol Chem; 2013 Aug; 288(31):22527-41. PubMed ID: 23775078
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase III is a new target of HIF1α in prostate cancer model.
Okuyan D; Aydogan Turkoglu S; Kockar F
Gene; 2020 Dec; 762():145034. PubMed ID: 32777521
[TBL] [Abstract][Full Text] [Related]
13. FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1.
Yu CP; Yu S; Shi L; Wang S; Li ZX; Wang YH; Sun CJ; Liang J
Mol Med Rep; 2017 Oct; 16(4):5181-5188. PubMed ID: 28849004
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer.
Li Y; Zhang D; Wang X; Yao X; Ye C; Zhang S; Wang H; Chang C; Xia H; Wang YC; Fang J; Yan J; Ying H
Sci Rep; 2015 Jul; 5():12495. PubMed ID: 26205124
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer.
Pan H; Zhu Y; Wei W; Shao S; Rui X
World J Surg Oncol; 2018 Mar; 16(1):59. PubMed ID: 29554906
[TBL] [Abstract][Full Text] [Related]
16. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
[TBL] [Abstract][Full Text] [Related]
17. HIF-1α and Nrf2 regulates hypoxia induced overexpression of DDAH1 through promoter activation in prostate cancer.
Parveen SMA; Natani S; Sruthi K K ; Khilar P; Ummanni R
Int J Biochem Cell Biol; 2022 Jun; 147():106232. PubMed ID: 35644470
[TBL] [Abstract][Full Text] [Related]
18. A novel HIF1α-STIL-FOXM1 axis regulates tumor metastasis.
Wang YW; Chen SC; Gu DL; Yeh YC; Tsai JJ; Yang KT; Jou YS; Chou TY; Tang TK
J Biomed Sci; 2022 Apr; 29(1):24. PubMed ID: 35365182
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 and androgen receptor co-regulate CDC6 gene transcription and DNA replication in prostate cancer cells.
Liu Y; Gong Z; Sun L; Li X
Biochim Biophys Acta; 2014; 1839(4):297-305. PubMed ID: 24583551
[TBL] [Abstract][Full Text] [Related]
20. PKM2 and HIF-1α regulation in prostate cancer cell lines.
Hasan D; Gamen E; Abu Tarboush N; Ismail Y; Pak O; Azab B
PLoS One; 2018; 13(9):e0203745. PubMed ID: 30216369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
